key: cord-0886562-r6u7lyl4
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: COVID-19 Vaccination in Hemodialysis Patients Correspondence
date: 2022-03-08
journal: High Blood Press Cardiovasc Prev
DOI: 10.1007/s40292-022-00510-z
sha: aedbb16fe5ed8a308d468b5c8100f9d482c7ad75
doc_id: 886562
cord_uid: r6u7lyl4

nan

We would like to share ideas on "Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study [1] ". Piscitani et al. noted that "This study supports the finding of hyporesponsiveness to mRNA vaccination among hemodialysis patients [1] ". The impact of COVID-19 vaccination on immunocompromised recipients is an interesting topic of research right now. In the event of hemodialysis, a reduced immune response is likely, which could influence the immune response to vaccination. Background immunological status could be a key factor influencing responsiveness [2] . An evaluation of the hemodialysis patient's immune function before vaccination could provide important information for determining the vaccine's effectiveness. Nevertheless, the impact of COVID-19 vaccine type should be considered. There is a difference in immunological response after immunization with different types of vaccines, according to a recent study [3] . 

Humoral immune response to COVID-19 vaccination in hemodialysis patients: a retrospective, observational case-control pilot study

The humoral immune response to BNT162b2 vaccine is associated with circulating CD19+ B lymphocytes and the naive CD45RA to memory CD45RO CD4+ T helper cells ratio in hemodialysis patients and kidney transplant recipients

Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis

The authors declare that they have no competing interest.